FDA Approves New Digital Sensor To Ensure ‘Patients With Mental Health Issues’ Take Their Meds

The Food and Drug Administration has just approved a new pill with a digital sensor in it. It will “ensure” that patients who suffer from mental health issues take their medicine when they are told. But privacy concerns have not gone unnoticed.

Regulators in the United States have approved the first bill that can be digitally tracked as it makes its way through the human body.  The Abilify MyCite aripiprazole tablets used for treating schizophrenia and manic episodes have an ingestible sensor embedded inside them that records that the medication has been taken. A patch worn by the patient transmits this information to their smartphone.

But many are raising the red flag that this could simply be another form of medical “big brother.” You may no longer have the right to refuse medications in the very near future.

The Abilify MyCite features a sensor the size of a grain


This post was originally published on this site
Comments are closed.